BRIEF-CANCER GENETICS INC REPORTS Q1 LOSS PER SHARE $0.51

* CANCER GENETICS INC ANNOUNCES 15% REVENUE INCREASE IN
FIRST QUARTER OF 2017 OVER 2016 ON STRONG ORGANIC GROWTH WHILE
CONTINUING ON PATH TO PROFITABILITY
Original Article